Skip to content
Trial Eligibility
Menu

Lupus Clinical Trials near Chicago, IL

15 studies for Lupus are recruiting at 19 sites within 50 miles of Chicago, Illinois, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lupus trials in the US or all trials near Chicago.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lupus studies enrolling near Chicago

Showing 15 studies, nearest first.
  1. The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

    NCT05538208

    • Phase 2
    • Ages 8 to 20 years
    • Sex: All

    Nearest sites: Ann & Robert H. Lurie Children's Hospital of Chicago (Chicago, IL); University of Chicago Medicine- Comer Children's (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  2. An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

    NCT05835310

    • Phase 3
    • Ages 5 to 17 years
    • Sex: All

    Nearest sites: Research Site (Chicago, IL); Research Site (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  3. RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

    NCT06121297

    • Phase 1/2
    • Ages 12 to 65 years
    • Sex: All

    Nearest sites: Northwestern Memorial Hospital (Chicago, IL); The University of Chicago Medical Center - Accepting Adult and Adolescent Patients (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  4. A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

    NCT06617325

    • Phase 3
    • Ages 16 years and older
    • Sex: All

    Nearest sites: Sl0044 50699 (Chicago, IL); Sl0044 50717 (Willowbrook, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  5. VIBRANT: VIB4920 for Active Lupus Nephritis

    NCT05201469

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Chicago, Department of Medicine: Rheumatology (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  6. Lupus Landmark Study: A Prospective Registry and Biorepository

    NCT05934149

    • Observational
    • Ages 18 to 110 years
    • Sex: All

    Nearest site: University of Chicago (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

    NCT06557265

    • Phase 1/2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Nkarta Investigational Site (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

    NCT06925542

    • Phase 1
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

    NCT07085104

    • Phase 1
    • Ages 18 to 74 years
    • Sex: All

    Nearest site: The University of Chicago Medical Center (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

    NCT06133972

    • Phase 3
    • Ages 12 to 100 years
    • Sex: All

    Nearest site: Willow Rheumatology Wellness (Willowbrook, IL)

    Distance to nearest recruiting site
    ~16 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

    NCT07175285

    • Observational
    • Ages 16 years and older
    • Sex: All

    Nearest site: Willow Rheumatology & Wellness (Willowbrook, IL)

    Distance to nearest recruiting site
    ~16 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

    NCT07430306

    • Phase 3
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Research Site (Willowbrook, IL)

    Distance to nearest recruiting site
    ~16 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

    NCT07438496

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Willow Rheumatology and Wellness PLLC (Willowbrook, IL)

    Distance to nearest recruiting site
    ~16 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

    NCT06977724

    • Phase 1
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Advanced Quality Medical Research /ID# 278462 (Orland Park, IL)

    Distance to nearest recruiting site
    ~19 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

    NCT07607964

    • Phase 1
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Advanced Quality Medical Research /ID# 279147 (Orland Park, IL)

    Distance to nearest recruiting site
    ~19 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lupus clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.